Cargando…
A Pilot Randomized Controlled Trial of Omega-3 Fatty Acids for Autism Spectrum Disorder
We conducted a pilot randomized controlled trial to determine the feasibility and initial safety and efficacy of omega-3 fatty acids (1.3 g/day) for the treatment of hyperactivity in 27 children ages 3–8 with autism spectrum disorder (ASD). After 12 weeks, hyperactivity, as measured by the Aberrant...
Autores principales: | Bent, Stephen, Bertoglio, Kiah, Ashwood, Paul, Bostrom, Alan, Hendren, Robert L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076562/ https://www.ncbi.nlm.nih.gov/pubmed/20683766 http://dx.doi.org/10.1007/s10803-010-1078-8 |
Ejemplares similares
-
Omega-3 Fatty Acids for Autistic Spectrum Disorder: A Systematic Review
por: Bent, Stephen, et al.
Publicado: (2009) -
Gene expression in blood is associated with risperidone response in children with autism spectrum disorders
por: Lit, Lisa, et al.
Publicado: (2011) -
Omega-3 polyunsaturated fatty acids and/or vitamin D in autism spectrum disorders: a systematic review
por: Jiang, Yuwei, et al.
Publicado: (2023) -
51.1 A QUALITATIVE ANALYSIS: THE EXPERIENCE OF PARENTS OF CHILDREN WITH AUTISM SPECTRUM DISORDER DURING THE COVID-19 PANDEMIC
por: Parenteau, China I., et al.
Publicado: (2020) -
Supplementation of omega 3 fatty acids may improve hyperactivity, lethargy, and stereotypy in children with autism spectrum disorders: a meta-analysis of randomized controlled trials
por: Cheng, Yu-Shian, et al.
Publicado: (2017)